Skip to content
10-Q

Quarterly Report

ArtVentive Medical Group, Inc.

0001056520-16-000248

← back to feed
Filed
May 16, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 16, 2016 63.64M sh
Operating Cash Flow Q1 2016 · Mar 31, 2016 −$26.68K
Operating Cash Flow Q1 2016 · Mar 31, 2015 −$670.61K
Long Term Debt Q1 2016 · Mar 31, 2016 $500K
Long Term Debt Q1 2016 · Dec 31, 2015 $500K
Cash And Equivalents Q1 2016 · Mar 31, 2016 $10.11K
Cash And Equivalents Q1 2016 · Dec 31, 2015 $21.78K
Stockholders Equity Q1 2016 · Mar 31, 2016 −$1.5M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$970.67K
Current Liabilities Q1 2016 · Mar 31, 2016 $1.44M
Current Liabilities Q1 2016 · Dec 31, 2015 $924.09K
Current Assets Q1 2016 · Mar 31, 2016 $352.66K
Current Assets Q1 2016 · Dec 31, 2015 $354.6K
Total Assets Q1 2016 · Mar 31, 2016 $446.11K
Total Assets Q1 2016 · Dec 31, 2015 $453.42K
Sga Expense Q1 2016 · Mar 31, 2016 $362.16K
Sga Expense Q1 2016 · Mar 31, 2015 $585.33K
Rd Expense Q1 2016 · Mar 31, 2016 $179.65K
Rd Expense Q1 2016 · Mar 31, 2015 $301.93K
Net Income Q1 2016 · Mar 31, 2016 −$543.04K
Net Income Q1 2016 · Mar 31, 2015 −$888.18K
Cost Of Revenue Q1 2016 · Mar 31, 2016 $45.99K
Cost Of Revenue Q1 2016 · Mar 31, 2015 $64.19K
Revenue Q1 2016 · Mar 31, 2016 $45.99K
Revenue Q1 2016 · Mar 31, 2015 $64.19K